ArticleEuropean cytokine network2021

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19).

Roman Maslennikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.